CorEvitas Multiple Sclerosis (MS) Registry

Enrolling by invitation

Conditions studied: Multiple Sclerosis

In brief

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for MS in a cohort of patients cared for by neurologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.

Key facts

Study ID

NCT03291756

Run by

CorEvitas

People needed

1000

Starts

2017-08-10

Expected to finish

2100-12-01

Last updated by the study team

2026-02-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Has a diagnosis of MS at the time of enrollment.
• Age 18 years or older at the time of enrollment.
• Willing to provide Personal Information.
• Initiating (prescribed or starting) an Eligible Medication for the treatment of MS at the enrollment visit.

You may not qualify if…

• Is participating or planning to participate in a double-blind randomized trial for an MS drug. Note: Concurrent participation in another observational registry or open-label Phase 3b/4 trial is allowed.

Where it is running

• CorEvitas, LLC — Waltham, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.